| Iressa治疗非小细胞肺癌的进展 |
| |
| 引用本文： | 许亚萍,马胜林,魏启春. Iressa治疗非小细胞肺癌的进展[J]. 国外医学(肿瘤学分册), 2006, 0(9) |
| |
| 作者姓名： | 许亚萍 马胜林 魏启春 |
| |
| 作者单位： | 浙江大学医学院附属第二医院放疗科，浙江大学医学院附属第二医院放疗科，浙江大学医学院附属第二医院放疗科 |
| |
| 摘 要： | 分子靶向药物,如表皮生长因子受体酪氨酸激酶抑制剂,是近年来在血液和实体肿瘤治疗中涌现出的新治疗手段。现就表皮生长因子受体酪氨酸激酶抑制剂Iressa在非小细胞肺癌治疗中的进展作一综述。
|
| 关 键 词： | 抗肿瘤药 癌 非小细胞肺 受体 表皮生长因子 |
Treatment of non-small cell lung cancer with Iressa |
| |
| XU Ya-ping. Treatment of non-small cell lung cancer with Iressa[J]. Foreign Medical Sciences (Cancer Section), 2006, 0(9) |
| |
| Authors: | XU Ya-ping |
| |
| Affiliation: | XU Ya-ping. Department of Radiation Oncology,Second Affiliated Hospital of Medical College,Zhejiang University,Hangzhou 310009,China |
| |
| Abstract: | Molecular targeted therapies, such as the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors ( TKI) , have emerged as a novel approach to the treatment of both hematological and solid tumors in recent years. This paper reviews the progress in treatment of non- small cell lung cancer with Iressa. |
| |
| Keywords: | Antineoplastic agents Carcinoma non- small cell lung Receptor epidermal growth factor |
| 本文献已被 CNKI 等数据库收录！ |
